Ivan K. Fong's most recent trade in Medtronic Plc was a trade of 532 Ordinary Shares done at an average price of $82.5 . Disclosure was reported to the exchange on Dec. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.48 per share. | 16 Dec 2024 | 532 | 54,692 (0%) | 0% | 82.5 | 43,879 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 10 Dec 2024 | 3,009 | 55,224 (0%) | 0% | 83.6 | 251,492 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 8,370 | 61,029 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 8,370 | 0 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 6,144 | 63,750 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 6,144 | 0 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 3,423 | 57,606 (0%) | 0% | 81.5 | 279,009 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 2,985 | 57,963 (0%) | 0% | 81.5 | 243,307 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.51 per share. | 02 Aug 2024 | 2,802 | 60,948 (0%) | 0% | 81.5 | 228,391 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 94,248 | 92,248 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 31,875 | 31,875 | - | - | Performance Share Unit | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 12,750 | 52,659 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan Fong K. | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.35 per share. | 08 Dec 2023 | 1,952 | 39,201 (0%) | 0% | 79.3 | 154,891 | Ordinary Shares |
| Medtronic | K. Fong Ivan | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.27 per share. | 08 Dec 2023 | 716 | 40,091 (0%) | 0% | 79.3 | 56,757 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 56,162 | 56,162 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 19,941 | 19,941 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 7,977 | 40,807 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.59 per share. | 09 Dec 2022 | 5,206 | 32,830 (0%) | 0% | 78.6 | 409,140 | Ordinary Shares |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 54,849 | 54,849 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 17,351 | 17,351 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 6,941 | 37,722 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 145,852 | 145,852 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 50,476 | 50,476 | - | - | Stock Option (Right to Buy) | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 24,134 | 30,371 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 21,238 | 21,238 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 15,591 | 15,591 | - | - | Performance Share Units | |
| Medtronic | Ivan K. Fong | EVP GENERAL COUNSEL & SECR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 6,237 | 6,237 (0%) | 0% | 0 | Ordinary Shares | |
| 3M | Ivan K. Fong | Exec VP, Gen Counsel & Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 12,059 | 23,291 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | Ivan K. Fong | Exec VP, Gen Counsel & Secret | Sale of securities on an exchange or to another person at price $ 198.46 per share. | 30 Apr 2021 | 12,059 | 35,813 (0%) | 0% | 198.5 | 2,393,229 | Common Stock |
| 3M | Ivan K. Fong | Exec VP, Gen Counsel & Secret | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.25 per share. | 30 Apr 2021 | 12,059 | 47,872 (0%) | 0% | 89.3 | 1,076,266 | Common Stock |
| 3M | Ivan K. Fong | SVP, Gen Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Feb 2021 | 113 | 35,562 (0%) | 0% | 0 | Common Stock | |
| 3M | Ivan K. Fong | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.25 per share. | 16 Nov 2020 | 15,073 | 47,885 (0%) | 0% | 89.2 | 1,345,265 | Common Stock |
| 3M | Ivan K. Fong | SVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Nov 2020 | 15,073 | 35,350 | - | - | Non-qualified Stock Option (Right to Buy) | |
| 3M | Ivan K. Fong | SVP, Gen Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 172.62 per share. | 16 Nov 2020 | 15,073 | 32,812 (0%) | 0% | 172.6 | 2,601,901 | Common Stock |